VIDAS TOXOPLASMA GONDII IGM ASSSAY— 510(k) K923166

Name: FDA 510(k) clearance K923166
Creator: U.S. Food and Drug Administration
Published: 1993-02-25

Substantially Equivalent

Biomerieux Vitek, Inc.

FDA 510(k) clearance K923166 for VIDAS TOXOPLASMA GONDII IGM ASSSAY, Substantially Equivalent on 1993-02-25. Applicant: Biomerieux Vitek, Inc.. Device class: 2.

Clearance details

Applicant: Biomerieux Vitek, Inc.
Product code: Code LGD
Device class: Class 2
Regulation: 21 CFR 866.3780
Advisory panel: Microbiology
Date received: 1992-06-29
Decision date: 1993-02-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rockland, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGD

view all

K242022 — Access Toxo IgG2025-03-28
K242095 — Access Toxo IgM II2024-10-11
K233932 — Alinity i Toxo IgM2024-08-30
K210596 — ARCHITECT Toxo IgG2022-05-19
K162678 — Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl2017-06-23

More clearances from Biomerieux Vitek, Inc.

view all

K973819 — VIDAS D-DIMER (DD) ASSAY1998-03-10
K972895 — VIDAS ROTAVIRUS (RTV) ASSAY1997-10-03
K965092 — VIDAS ROTAVIRUS ASSAY1997-05-05
K964887 — VIDAS C. DIFFICILE TOXIN A II ASSAY1997-04-08
K955627 — VIDAS CHLAMYDIA BLOCKING ASSAY1996-10-07

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.